Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJeanne Tie, Peter Gibbs, Joshua D. Cohen et al.|JAMA Oncology|2019Cited by 694
Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.Nadia Hitchen, Jeanne Tie, Belinda Lee et al.|Journal of Clinical Oncology|2025Cited by 1
Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC).Vanessa Wong, Peter Gibbs, Grace Kim et al.|Journal of Clinical Oncology|2026Cited by 0